150 related articles for article (PubMed ID: 9007592)
1. High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patients.
Riederer AP; Grein GO; Bogner JR
Infection; 1996; 24(6):440-6. PubMed ID: 9007592
[No Abstract] [Full Text] [Related]
2. [Ear, nose and throat pathology in human immunodeficiency virus infection].
Benhammou A; Benbouzid A; El Messaoudi A; Jazouli N; Kzadri M
East Mediterr Health J; 2002 Nov; 8(6):826-31. PubMed ID: 15568461
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus in otolaryngology.
Youngs R
J Laryngol Otol; 1997 Mar; 111(3):209-11. PubMed ID: 9156053
[No Abstract] [Full Text] [Related]
4. Head and neck manifestations of AIDS in adults.
Moazzez AH; Alvi A
Am Fam Physician; 1998 Apr; 57(8):1813-22. PubMed ID: 9575321
[TBL] [Abstract][Full Text] [Related]
5. Otorhinolaryngological manifestations of HIV/AIDS in Lagos.
Somefun A; Nwawolo CC; Okeowo PA; Ogban LU; Akanmu AS; Okanny CC; Akinsete I
Niger Postgrad Med J; 2001 Dec; 8(4):170-4. PubMed ID: 11922022
[TBL] [Abstract][Full Text] [Related]
6. Head, neck and ophthalmologic manifestations of HIV in the emergency department.
Moayedi S
Emerg Med Clin North Am; 2010 May; 28(2):265-71. PubMed ID: 20413010
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis in the head and neck: experience in India.
Prasad KC; Sreedharan S; Chakravarthy Y; Prasad SC
J Laryngol Otol; 2007 Oct; 121(10):979-85. PubMed ID: 17367564
[TBL] [Abstract][Full Text] [Related]
8. Otolaryngological, head and neck manifestations in HIV-infected patients seen at Steve Biko Academic Hospital in Pretoria, South Africa.
Tshifularo M; Govender L; Monama G
S Afr Med J; 2013 May; 103(7):464-6. PubMed ID: 23802209
[TBL] [Abstract][Full Text] [Related]
9. [Cervico-facial and ENT symptoms due to HIV infection in tropical area. About 253 Congolese cases].
Ondzotto G; Ibara JR; Mowondabeka P; Galiba J
Bull Soc Pathol Exot; 2004 Feb; 97(1):59-63. PubMed ID: 15104161
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
[TBL] [Abstract][Full Text] [Related]
11. Otorhinolaryngologic manifestations of acquired immunodeficiency syndrome.
Sant'Anna GD; Franche GL; Tabajara LM; Favero RM; Kuhl G
Rev Laryngol Otol Rhinol (Bord); 1991; 112(1):63-6. PubMed ID: 2052790
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
Ariyoshi K; Schim van der Loeff M; Cook P; Whitby D; Corrah T; Jaffar S; Cham F; Sabally S; O'Donovan D; Weiss RA; Schulz TF; Whittle H
J Hum Virol; 1998; 1(3):193-9. PubMed ID: 10195242
[TBL] [Abstract][Full Text] [Related]
13. [Facial and cervical manifestations of AIDS].
Gebrim EM; Gomes RL; Bambirra S; Rocha Mde S
Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(4):222-6. PubMed ID: 8560153
[TBL] [Abstract][Full Text] [Related]
14. Otorhinolaryngological aspects of HIV infections: personal experience.
Zambetti G; Luce M; Ciofalo A; Leonardi M; Filiaci F
Allergol Immunopathol (Madr); 1994; 22(5):192-6. PubMed ID: 7840019
[TBL] [Abstract][Full Text] [Related]
15. [Otorhinolaryngologic manifestations in patients infected by the acquired immunodeficiency virus].
Riederer A; Bujía J; Vogel T; Wilmes E; Kastenbauer E
Acta Otorrinolaringol Esp; 1990; 41(5):277-80. PubMed ID: 2076306
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection in women infected with the human immunodeficiency virus.
Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women.
Stover CT; Smith DK; Schmid DS; Pellett PE; Stewart JA; Klein RS; Mayer K; Vlahov D; Schuman P; Cannon MJ;
J Infect Dis; 2003 May; 187(9):1388-96. PubMed ID: 12717619
[TBL] [Abstract][Full Text] [Related]
18. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.
Yazdanpanah Y; Chêne G; Losina E; Goldie SJ; Merchadou LD; Alfandari S; Seage GR; Sullivan L; Marimoutou C; Paltiel AD; Salamon R; Mouton Y; Freedberg KA
Int J Epidemiol; 2001 Aug; 30(4):864-71. PubMed ID: 11511618
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of parvovirus B19 infection among patients with human immunodeficiency virus infection in Barcelona, Spain.
Negredo E; Domingo P; Rabella N; López-Contreras J; Fontanet A; Orellana I
Arch Intern Med; 1998 Mar; 158(6):680-1. PubMed ID: 9521236
[No Abstract] [Full Text] [Related]
20. Prevalence of and factors related to tuberculosis in seropositive human immunodeficiency virus patients at a reference center for treatment of human immunodeficiency virus in the southern region of the state of Rio Grande do Sul, Brazil.
Silveira JM; Sassi RA; de Oliveira Netto IC; Hetzel JL
J Bras Pneumol; 2006; 32(1):48-55. PubMed ID: 17273569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
